slides · global inventory
Evidence
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 40,452
Current window 18,661-18,690
Pages 1,349
Rows per page 30
Beat
18,661-18,690 of 40,452
16
The slide highlights Allego's strategic focus on Ultra-Fast charging.Allego | SPAC Presentation Deck | 37 slides · Allego
Pitch deck Investment bank Beat · Market Size1 hit
29
The slide illustrates the diversity of autoantibodies in myositis patients, supporting the thesis that a broad-acting therapy like Efgartigimod is effective.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
30
argenx SE | Investor Day Presentation Deck | 69 slidesargenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
31
The slide shows 8 individual patient longitudinal plots. Each plot has dual y-axes (CK and Anti-SRP54) and a shared x-axis (Days).argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
32
The chart is a Kaplan-Meier survival curve showing 'DOI-free Survival Probability' over time in weeks.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
33
ProDERM study data comparing IVIg and placebo efficacy over time.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
34
Includes two dot plots showing grip/muscle strength and two microscopy images showing necrosis and complement deposition.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
35
The chart uses a diagonal line to represent growth or accumulation of patient segments.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
36
The slide outlines a clinical trial protocol involving 180 patients, stratified by condition and severity, with a 26-week duration and specific primary/secondary endpoints.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
37
argenx SE | Investor Day Presentation Deck | 69 slidesargenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
38
argenx SE | Investor Day Presentation Deck | 69 slidesargenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
39
The slide uses a structured 4-column layout to summarize the disease profile.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
40
The slide depicts a step-by-step biological pathway (1-6) showing how autoantibodies lead to blister formation. It also highlights the therapeutic target Efgartigimod.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
41
The slide uses a before-after structure to contrast WT mice (susceptible) with FcRn-/- mice (resistant) and shows the impact of HDIG treatment.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
42
The funnel structure implies a progression toward higher selectivity and better outcomes.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
43
The slide presents three distinct clinical datasets (IVIg, Protein A Immunoadsorption, and PLEX) to support the thesis that IgG-targeted therapies lead to fast remissions.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
08
The slide uses a Venn-like diagram to connect three core pillars to six specific business outcomes.argenx SE | Results Presentation Deck | 16 slides · argenx
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
The diagram is a variation of a flywheel or infinity loop representing a virtuous cycle of innovation.argenx SE | Results Presentation Deck | 16 slides · argenx
Conference presentation Investor relations Beat · Market SizeLoop · Golden Circle1 hit
10
The slide uses a biological metaphor (neuron) to represent corporate strategy and portfolio integration.argenx SE | Results Presentation Deck | 16 slides · argenx
Conference presentation Investor relations Beat · Market SizeLoop · Golden Circle1 hit
11
Financial data presented in thousands of dollars except for shares and EPS.argenx SE | Results Presentation Deck | 16 slides · argenx
Conference presentation Investor relations Beat · Financials1 hit
12
The slide uses a three-column layout to highlight different patient engagement platforms.argenx SE | Results Presentation Deck | 16 slides · argenx
Conference presentation Investor relations Beat · Financials1 hit
08
The slide uses a waterfall chart to explain the variance in EBITDA, followed by a detailed PBT reconciliation table.Aston Martin | Results Presentation Deck | 25 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Evidence & ProofLoop · Mece Breakdown1 hit
09
The chart uses a standard waterfall bridge format to reconcile PBT to Free Cash Flow.Aston Martin | Results Presentation Deck | 25 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Evidence & ProofLoop · Mece Breakdown1 hit
33
Statistics as of July 1, 2021.Babylon | SPAC Presentation Deck | 100 slides · Babylon
Conference presentation Investment bank Beat · Market Size1 hit
34
Statistics as of July 1, 2021.Babylon | SPAC Presentation Deck | 100 slides · Babylon
Conference presentation Investment bank Beat · Market Size1 hit
44
Babylon | SPAC Presentation Deck | 100 slidesBabylon | SPAC Presentation Deck | 100 slides · Babylon
Conference presentation Investment bank Beat · Product1 hit
45
Babylon | SPAC Presentation Deck | 100 slidesBabylon | SPAC Presentation Deck | 100 slides · Babylon
Conference presentation Investment bank Beat · Product1 hit
46
The slide uses a horizontal process flow to categorize services into 'Self Care' (Software Licensing) and 'Sick Care Management'.Babylon | SPAC Presentation Deck | 100 slides · Babylon
Conference presentation Investment bank Beat · Product1 hit
47
The slide uses a process bar at the top to highlight 'Assess' as the current stage of the holistic care journey.Babylon | SPAC Presentation Deck | 100 slides · Babylon
Conference presentation Investment bank Beat · Product1 hit
48
The slide uses a process-flow header (Engage, Assess, Plan, Monitor, Treat, Support) with 'Plan' highlighted.Babylon | SPAC Presentation Deck | 100 slides · Babylon
Conference presentation Investment bank Beat · Product1 hit